ArticleCureus2025
The Prevalence and Determinants of Long-Term Glycemic Control Based on Serial Glycosylated Haemoglobin Values in Type 2 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiabetes mellitus has become a significant public health issue in India, with a considerable proportion of the population living with the condition. Type 2 Diabetes Mellitus (T2DM), commonly linked with obesity, is associated with metabolic abnormalities and vascular complications. Effective long-term glycemic control is important in preventing complications and improving patient outcomes.
objectiveTo examine associations between demographic, anthropometric, clinical, and therapeutic characteristics and long-term glycemic control status in individuals with T2DM in 314 participants. Methodology and results: This is a longitudinal study conducted to evaluate factors such as demographic characteristics, clinical parameters, duration of T2DM, medication use, and comorbidities. Findings highlight the impact of age, gender, obesity, medication adherence, and comorbid conditions on glycemic control.
conclusionA multi-faceted approach, including lifestyle modifications, personalized treatment plans, and patient education, is essential for achieving optimal glycemic outcomes in T2DM management. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.